M. L. Mar

Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States

M. Markowitz, R. Grant, P. Defechereux, 2018, AIDS and Behavior.

Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants

D. Dunbar, I. Frank, H. Tieu, 2018, AIDS and Behavior.

Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report

D. Ho, T. Wrin, C. Petropoulos, 2005, The Lancet.